United States Healthcare Providers & Services

Oncology Institute Inc (TOI)

Track

Over the past ninety days, Oncology Institute Inc. witnessed twelve insider trading transactions. While Jorey Chernett aggressively accumulated shares, Chief Medical Officer Yale Podnos executed multiple sales. These activities occurred amidst a 28.2% stock price increase, following the most recent earnings report released in August 2026.
Ticker: TOI Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Oncology Institute Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.8
Chernett Jorey Large shareholder
Transaction date
Purchase
Price
415.63
Quantity 10,731 +41.3%
Value US$290,536
Podnos Yale Chief Medical Officer Officer
Transaction date
Sale
Price
420.42
Quantity 96,843 -11.5%
Value US$4,879,964
Podnos Yale Chief Medical Officer Officer
Transaction date
Sale
Price
38.64
Quantity 80,235 +20.1%
Value US$416,126
YALE PODNOS Officer Officer
Transaction date
Proposed sale
Price
6.25
Quantity 23,452
Value US$146,575
3.8
Chernett Jorey Large shareholder
Transaction date
Purchase
Price
5.85
Quantity 15,000 +0.1%
Value US$87,750
3.8
Chernett Jorey Large shareholder
Transaction date
Purchase
Price
5.02
Quantity 18,000 +0.2%
Value US$90,360
Podnos Yale Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.38
Quantity 23,451 -8.3%
Value US$126,094
YALE PODNOS Officer Officer
Transaction date
Proposed sale
Price
4.87
Quantity 23,451
Value US$114,206
3.8
Chernett Jorey Large shareholder
Transaction date
Purchase
Price
4.75
Quantity 12,000 +0.1%
Value US$57,000
3.8
Chernett Jorey Large shareholder
Transaction date
Purchase
Price
4.07
Quantity 33,500 +0.3%
Value US$136,345
3.8
Chernett Jorey Large shareholder
Transaction date
Purchase
Price
4.05
Quantity 5,000 +0.0%
Value US$20,250
3.8
Chernett Jorey Large shareholder
Transaction date
Purchase
Price
4.09
Quantity 30,000 +0.3%
Value US$122,700
Kaushal Mohit Non-Executive Director
Transaction date
Planned sale
Price
3.50
Quantity 38,433 -18.2%
Value US$134,535
Kaushal Mohit Non-Executive Director
Transaction date
Planned sale
Price
3.50
Quantity 57,286 -21.4%
Value US$200,598
MOHIT KAUSHAL Director Non-Executive Director
Transaction date
Proposed sale
Price
3.30
Quantity 95,719
Value US$315,873
3.8
Chernett Jorey Large shareholder
Transaction date
Purchase
Price
3.10
Quantity 20,000 +0.2%
Value US$62,000
3.8
Chernett Jorey Large shareholder
Transaction date
Purchase
Price
2.96
Quantity 27,429 +0.3%
Value US$81,190
3.8
Chernett Jorey Large shareholder
Transaction date
Purchase
Price
3.15
Quantity 50,000 +0.5%
Value US$157,500
3.8
Chernett Jorey Large shareholder
Transaction date
Purchase
Price
3.11
Quantity 125,000 +1.2%
Value US$388,750
3.8
Chernett Jorey Large shareholder
Transaction date
Purchase
Price
3.35
Quantity 25,000 +0.2%
Value US$83,750
3.8
Chernett Jorey Large shareholder
Transaction date
Purchase
Price
3.42
Quantity 75,000 +0.7%
Value US$256,500
3.8
Chernett Jorey Large shareholder
Transaction date
Purchase
Price
3.29
Quantity 60,985 +0.6%
Value US$200,641
3.8
Chernett Jorey Large shareholder
Transaction date
Purchase
Price
2.92
Quantity 263,000 +2.7%
Value US$767,960
2.4
Carter Robert Ross Chief Financial Officer Officer
Transaction date
Sale
Price
3.56
Quantity 247 -0.1%
Value US$879
3.1
Hively Brad Non-Executive Director
Transaction date
Sale
Price
3.77
Quantity 13,333 -1.9%
Value US$50,291
3.1
BRADFORD DANIEL HIVELY Director Non-Executive Director
Transaction date
Proposed sale
Price
3.77
Quantity 13,333
Value US$50,291
3.1
Pacala Mark L Non-Executive Director
Transaction date
Sale
Price
4.00
Quantity 46,630 -21.0%
Value US$186,520
3.1
Pacala Mark L Non-Executive Director
Transaction date
Sale
Price
4.00
Quantity 1,210 -0.5%
Value US$4,840
3.1
Pacala Mark L Non-Executive Director
Transaction date
Sale
Price
4.00
Quantity 2,160 -1.0%
Value US$8,640
3.1
MARK PACALA Director Non-Executive Director
Transaction date
Proposed sale
Price
4.00
Quantity 50,000
Value US$200,000
1.8
M33 Growth I L.P. Non-Executive Director Large shareholder
Transaction date
Sale
Price
3.09
Quantity 681,832 -53.6%
Value US$2,106,861
1.8
M33 Growth I L.P. Non-Executive Director Large shareholder
Transaction date
Sale
Price
3.09
Quantity 6,018,168 -43.1%
Value US$18,596,139
3.1
Hively Brad Non-Executive Director
Transaction date
Sale
Price
4.06
Quantity 20,221 -3.1%
Value US$82,097
1.8
M33 Growth I L.P. Non-Executive Director Large shareholder
Transaction date
Sale
Price
3.05
Quantity 76,324 -5.7%
Value US$232,788
1.8
M33 Growth I L.P. Non-Executive Director Large shareholder
Transaction date
Sale
Price
3.05
Quantity 673,676 -4.6%
Value US$2,054,712
TOI M, LLC 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
3.20
Quantity 127,207
Value US$407,062
1.8
M33 Growth I L.P. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
3.20
Quantity 1,122,793
Value US$3,592,938
3.1
Hively Brad Non-Executive Director
Transaction date
Sale
Price
2.87
Quantity 108,532 -15.2%
Value US$311,519
3.1
Hively Brad Non-Executive Director
Transaction date
Sale
Price
2.87
Quantity 1,867,605 -72.4%
Value US$5,360,587
3.1
BRADFORD DANIEL HIVELY Director Non-Executive Director
Transaction date
Proposed sale
Price
2.87
Quantity 39,600
Value US$113,652
3.1
BRADFORD DANIEL HIVELY Director Non-Executive Director
Transaction date
Proposed sale
Price
2.87
Quantity 1,936,537
Value US$5,557,861
1.8
M33 Growth I L.P. Non-Executive Director Large shareholder
Transaction date
Sale
Price
2.71
Quantity 203,532 -13.1%
Value US$552,162
1.8
M33 Growth I L.P. Non-Executive Director Large shareholder
Transaction date
Sale
Price
2.71
Quantity 1,796,468 -10.9%
Value US$4,873,638
TOI M, LLC 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
3.06
Quantity 203,532
Value US$622,808
1.8
M33 Growth I L.P. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
3.06
Quantity 1,796,468
Value US$5,497,192
Virnich Daniel Chief Executive Officer Officer
Transaction date
Purchase
Price
1.04
Quantity 22,640 +3.2%
Value US$23,584
3.1
Pacala Mark L Non-Executive Director
Transaction date
Purchase
Price
1.04
Quantity 90,562 +67.4%
Value US$94,338
Podnos Yale Chief Medical Officer Officer
Transaction date
Purchase
Price
1.04
Quantity 9,056 +12.9%
Value US$9,434
3.1
Hively Brad Non-Executive Director
Transaction date
Purchase
Price
1.04
Quantity 9,056 +1.4%
Value US$9,434
Castle Jeremy Chief Operating Officer Officer
Transaction date
Purchase
Price
1.04
Quantity 9,056 +11.1%
Value US$9,434
Johnson Karen Marie Non-Executive Director
Transaction date
Purchase
Price
1.04
Quantity 36,224 +21.7%
Value US$37,735
2.4
Carter Robert Ross Chief Financial Officer Officer
Transaction date
Purchase
Price
1.04
Quantity 9,056 +29.8%
Value US$9,434
3.0
BARASCH RICHARD A Non-Executive Director
Transaction date
Purchase
Price
1.04
Quantity 1,358,448 +325.6%
Value US$1,415,095
3.1
Hively Brad Non-Executive Director
Transaction date
Purchase
Price
0.15
Quantity 50,000 +8.1%
Value US$7,500
3.1
Hively Brad Non-Executive Director
Transaction date
Purchase
Price
0.17
Quantity 250,000 +68.2%
Value US$42,500
3.1
Shah Mihir Chief Financial Officer Officer
Transaction date
Purchase
Price
1.25
Quantity 565 +0.2%
Value US$706
3.1
Shah Mihir Chief Financial Officer Officer
Transaction date
Purchase
Price
1.27
Quantity 99,435 +43.6%
Value US$126,282
3.1
Hively Brad Non-Executive Director
Transaction date
Sale
Price
2.24
Quantity 25,000 -3.5%
Value US$56,000
3.1
Hively Brad Director Non-Executive Director
Transaction date
Proposed sale
Price
2.24
Quantity 25,000
Value US$56,000
3.1
Hively Brad Non-Executive Director
Transaction date
Sale
Price
2.52
Quantity 47,000 -6.1%
Value US$118,581
3.1
Hively Brad Director Non-Executive Director
Transaction date
Proposed sale
Price
2.52
Quantity 47,000
Value US$118,589
3.0
BARASCH RICHARD A Non-Executive Director
Transaction date
Purchase
Price
0.55
Quantity 10,000 +4.0%
Value US$5,500
3.0
BARASCH RICHARD A Non-Executive Director
Transaction date
Purchase
Price
0.55
Quantity 10,000 +4.2%
Value US$5,500
3.0
BARASCH RICHARD A Non-Executive Director
Transaction date
Purchase
Price
0.55
Quantity 2,146 +0.9%
Value US$1,176
3.0
BARASCH RICHARD A Non-Executive Director
Transaction date
Purchase
Price
0.55
Quantity 7,654 +3.4%
Value US$4,210
3.0
BARASCH RICHARD A Non-Executive Director
Transaction date
Purchase
Price
0.55
Quantity 9,948 +4.6%
Value US$5,471
3.0
BARASCH RICHARD A Non-Executive Director
Transaction date
Purchase
Price
0.55
Quantity 200 +0.1%
Value US$110
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-22 2026-07-21 B Purchase
3.8
Chernett Jorey
Large shareholder
10,731 +41.3%
415.63
US$290,536 		10,731 +41.3% 415.63 US$290,536
2026-07-16 2026-07-14 S Sale
Podnos Yale

Chief Medical Officer

Officer
96,843 -11.5%
420.42
US$4,879,964 		96,843 -11.5% 420.42 US$4,879,964
2026-07-16 2026-07-14 S Sale
Podnos Yale

Chief Medical Officer

Officer
80,235 +20.1%
38.64
US$416,126 		80,235 +20.1% 38.64 US$416,126
2026-07-14 2026-07-14 PrS Proposed sale
YALE PODNOS

Officer

Officer
23,452
6.25
US$146,575 		23,452 6.25 US$146,575
2026-07-13 2026-07-10 B Purchase
3.8
Chernett Jorey
Large shareholder
15,000 +0.1%
5.85
US$87,750 		15,000 +0.1% 5.85 US$87,750
2026-06-24 2026-06-23 B Purchase
3.8
Chernett Jorey
Large shareholder
18,000 +0.2%
5.02
US$90,360 		18,000 +0.2% 5.02 US$90,360
2026-06-09 2026-06-08 PlS Planned sale
Podnos Yale

Chief Medical Officer

Officer
23,451 -8.3%
5.38
US$126,094 		23,451 -8.3% 5.38 US$126,094
2026-06-08 2026-06-08 PrS Proposed sale
YALE PODNOS

Officer

Officer
23,451
4.87
US$114,206 		23,451 4.87 US$114,206
2026-06-05 2026-06-04 B Purchase
3.8
Chernett Jorey
Large shareholder
12,000 +0.1%
4.75
US$57,000 		12,000 +0.1% 4.75 US$57,000
2026-05-21 2026-05-20 B Purchase
3.8
Chernett Jorey
Large shareholder
33,500 +0.3%
4.07
US$136,345 		33,500 +0.3% 4.07 US$136,345
2026-05-21 2026-05-19 B Purchase
3.8
Chernett Jorey
Large shareholder
5,000 +0.0%
4.05
US$20,250 		5,000 +0.0% 4.05 US$20,250
2026-05-20 2026-05-19 B Purchase
3.8
Chernett Jorey
Large shareholder
30,000 +0.3%
4.09
US$122,700 		30,000 +0.3% 4.09 US$122,700
2026-04-16 2026-04-16 PlS Planned sale
Kaushal Mohit
Non-Executive Director
38,433 -18.2%
3.50
US$134,535 		38,433 -18.2% 3.50 US$134,535
2026-04-16 2026-04-14 PlS Planned sale
Kaushal Mohit
Non-Executive Director
57,286 -21.4%
3.50
US$200,598 		57,286 -21.4% 3.50 US$200,598
2026-04-14 2026-04-14 PrS Proposed sale
MOHIT KAUSHAL

Director

Non-Executive Director
95,719
3.30
US$315,873 		95,719 3.30 US$315,873
2026-04-13 2026-04-09 B Purchase
3.8
Chernett Jorey
Large shareholder
20,000 +0.2%
3.10
US$62,000 		20,000 +0.2% 3.10 US$62,000
2026-03-30 2026-03-27 B Purchase
3.8
Chernett Jorey
Large shareholder
27,429 +0.3%
2.96
US$81,190 		27,429 +0.3% 2.96 US$81,190
2026-03-27 2026-03-26 B Purchase
3.8
Chernett Jorey
Large shareholder
50,000 +0.5%
3.15
US$157,500 		50,000 +0.5% 3.15 US$157,500
2026-03-25 2026-03-24 B Purchase
3.8
Chernett Jorey
Large shareholder
125,000 +1.2%
3.11
US$388,750 		125,000 +1.2% 3.11 US$388,750
2026-03-23 2026-03-20 B Purchase
3.8
Chernett Jorey
Large shareholder
25,000 +0.2%
3.35
US$83,750 		25,000 +0.2% 3.35 US$83,750
2026-03-17 2026-03-17 B Purchase
3.8
Chernett Jorey
Large shareholder
75,000 +0.7%
3.42
US$256,500 		75,000 +0.7% 3.42 US$256,500
2026-03-17 2026-03-16 B Purchase
3.8
Chernett Jorey
Large shareholder
60,985 +0.6%
3.29
US$200,641 		60,985 +0.6% 3.29 US$200,641
2026-03-17 2026-03-13 B Purchase
3.8
Chernett Jorey
Large shareholder
263,000 +2.7%
2.92
US$767,960 		263,000 +2.7% 2.92 US$767,960
2026-01-05 2026-01-02 S Sale
2.4
Carter Robert Ross

Chief Financial Officer

Officer
247 -0.1%
3.56
US$879 		247 -0.1% 3.56 US$879
2025-12-16 2025-12-15 S Sale
3.1
Hively Brad
Non-Executive Director
13,333 -1.9%
3.77
US$50,291 		13,333 -1.9% 3.77 US$50,291
2025-12-15 2025-12-15 PrS Proposed sale
3.1
BRADFORD DANIEL HIVELY

Director

Non-Executive Director
13,333
3.77
US$50,291 		13,333 3.77 US$50,291
2025-11-20 2025-11-18 S Sale
3.1
Pacala Mark L
Non-Executive Director
46,630 -21.0%
4.00
US$186,520 		46,630 -21.0% 4.00 US$186,520
2025-11-20 2025-11-18 S Sale
3.1
Pacala Mark L
Non-Executive Director
1,210 -0.5%
4.00
US$4,840 		1,210 -0.5% 4.00 US$4,840
2025-11-20 2025-11-18 S Sale
3.1
Pacala Mark L
Non-Executive Director
2,160 -1.0%
4.00
US$8,640 		2,160 -1.0% 4.00 US$8,640
2025-11-18 2025-11-18 PrS Proposed sale
3.1
MARK PACALA

Director

Non-Executive Director
50,000
4.00
US$200,000 		50,000 4.00 US$200,000
2025-09-05 2025-09-04 S Sale
1.8
M33 Growth I L.P.
Non-Executive Director Large shareholder
681,832 -53.6%
3.09
US$2,106,861 		681,832 -53.6% 3.09 US$2,106,861
2025-09-05 2025-09-04 S Sale
1.8
M33 Growth I L.P.
Non-Executive Director Large shareholder
6,018,168 -43.1%
3.09
US$18,596,139 		6,018,168 -43.1% 3.09 US$18,596,139
2025-08-21 2025-08-19 S Sale
3.1
Hively Brad
Non-Executive Director
20,221 -3.1%
4.06
US$82,097 		20,221 -3.1% 4.06 US$82,097
2025-06-09 2025-06-05 S Sale
1.8
M33 Growth I L.P.
Non-Executive Director Large shareholder
76,324 -5.7%
3.05
US$232,788 		76,324 -5.7% 3.05 US$232,788
2025-06-09 2025-06-05 S Sale
1.8
M33 Growth I L.P.
Non-Executive Director Large shareholder
673,676 -4.6%
3.05
US$2,054,712 		673,676 -4.6% 3.05 US$2,054,712
2025-06-05 2025-06-05 PrS Proposed sale
TOI M, LLC

10% Stockholder

Large shareholder
127,207
3.20
US$407,062 		127,207 3.20 US$407,062
2025-06-05 2025-06-05 PrS Proposed sale
1.8
M33 Growth I L.P.

10% Stockholder

Large shareholder
1,122,793
3.20
US$3,592,938 		1,122,793 3.20 US$3,592,938
2025-06-05 2025-06-03 S Sale
3.1
Hively Brad
Non-Executive Director
108,532 -15.2%
2.87
US$311,519 		108,532 -15.2% 2.87 US$311,519
2025-06-05 2025-06-03 S Sale
3.1
Hively Brad
Non-Executive Director
1,867,605 -72.4%
2.87
US$5,360,587 		1,867,605 -72.4% 2.87 US$5,360,587
2025-06-03 2025-06-03 PrS Proposed sale
3.1
BRADFORD DANIEL HIVELY

Director

Non-Executive Director
39,600
2.87
US$113,652 		39,600 2.87 US$113,652
2025-06-03 2025-06-03 PrS Proposed sale
3.1
BRADFORD DANIEL HIVELY

Director

Non-Executive Director
1,936,537
2.87
US$5,557,861 		1,936,537 2.87 US$5,557,861
2025-05-22 2025-05-20 S Sale
1.8
M33 Growth I L.P.
Non-Executive Director Large shareholder
203,532 -13.1%
2.71
US$552,162 		203,532 -13.1% 2.71 US$552,162
2025-05-22 2025-05-20 S Sale
1.8
M33 Growth I L.P.
Non-Executive Director Large shareholder
1,796,468 -10.9%
2.71
US$4,873,638 		1,796,468 -10.9% 2.71 US$4,873,638
2025-05-20 2025-05-20 PrS Proposed sale
TOI M, LLC

10% Stockholder

Large shareholder
203,532
3.06
US$622,808 		203,532 3.06 US$622,808
2025-05-20 2025-05-20 PrS Proposed sale
1.8
M33 Growth I L.P.

10% Stockholder

Large shareholder
1,796,468
3.06
US$5,497,192 		1,796,468 3.06 US$5,497,192
2025-03-28 2025-03-26 B Purchase
Virnich Daniel

Chief Executive Officer

Officer
22,640 +3.2%
1.04
US$23,584 		22,640 +3.2% 1.04 US$23,584
2025-03-28 2025-03-26 B Purchase
3.1
Pacala Mark L
Non-Executive Director
90,562 +67.4%
1.04
US$94,338 		90,562 +67.4% 1.04 US$94,338
2025-03-28 2025-03-26 B Purchase
Podnos Yale

Chief Medical Officer

Officer
9,056 +12.9%
1.04
US$9,434 		9,056 +12.9% 1.04 US$9,434
2025-03-28 2025-03-26 B Purchase
3.1
Hively Brad
Non-Executive Director
9,056 +1.4%
1.04
US$9,434 		9,056 +1.4% 1.04 US$9,434
2025-03-28 2025-03-26 B Purchase
Castle Jeremy

Chief Operating Officer

Officer
9,056 +11.1%
1.04
US$9,434 		9,056 +11.1% 1.04 US$9,434
2025-03-28 2025-03-26 B Purchase
Johnson Karen Marie
Non-Executive Director
36,224 +21.7%
1.04
US$37,735 		36,224 +21.7% 1.04 US$37,735
2025-03-28 2025-03-26 B Purchase
2.4
Carter Robert Ross

Chief Financial Officer

Officer
9,056 +29.8%
1.04
US$9,434 		9,056 +29.8% 1.04 US$9,434
2025-03-28 2025-03-26 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
1,358,448 +325.6%
1.04
US$1,415,095 		1,358,448 +325.6% 1.04 US$1,415,095
2024-12-02 2024-12-02 B Purchase
3.1
Hively Brad
Non-Executive Director
50,000 +8.1%
0.15
US$7,500 		50,000 +8.1% 0.15 US$7,500
2024-12-02 2024-11-26 B Purchase
3.1
Hively Brad
Non-Executive Director
250,000 +68.2%
0.17
US$42,500 		250,000 +68.2% 0.17 US$42,500
2024-01-30 2024-01-29 S Sale
4.3
Havencrest Healthcare Partners, L.P.
Large shareholder
8,637 -100.0%
2.12
US$18,310 		8,637 -100.0% 2.12 US$18,310
2024-01-26 2024-01-26 S Sale
4.3
Havencrest Healthcare Partners, L.P.
Large shareholder
6,979 -44.7%
2.14
US$14,935 		6,979 -44.7% 2.14 US$14,935
2024-01-26 2024-01-25 S Sale
4.3
Havencrest Healthcare Partners, L.P.
Large shareholder
11,882 -43.2%
2.07
US$24,596 		11,882 -43.2% 2.07 US$24,596
2024-01-26 2024-01-24 S Sale
4.3
Havencrest Healthcare Partners, L.P.
Large shareholder
24,915 -47.5%
2.30
US$57,304 		24,915 -47.5% 2.30 US$57,304
2024-01-23 2024-01-23 S Sale
4.3
Havencrest Healthcare Partners, L.P.
Large shareholder
5,338 -9.2%
2.11
US$11,263 		5,338 -9.2% 2.11 US$11,263
2024-01-23 2024-01-22 S Sale
4.3
Havencrest Healthcare Partners, L.P.
Large shareholder
10,263 -15.1%
2.12
US$21,758 		10,263 -15.1% 2.12 US$21,758
2024-01-23 2024-01-19 S Sale
4.3
Havencrest Healthcare Partners, L.P.
Large shareholder
11,986 -15.0%
2.13
US$25,530 		11,986 -15.0% 2.13 US$25,530
2024-01-19 2024-01-19 PrS Proposed sale
Havencrest Healthcare Partners GP, LLC

10% Stockholder

Large shareholder
80,000
2.14
US$171,200 		80,000 2.14 US$171,200
2023-12-18 2023-12-14 B Purchase
3.1
Shah Mihir

Chief Financial Officer

Officer
565 +0.2%
1.25
US$706 		565 +0.2% 1.25 US$706
2023-12-18 2023-12-14 B Purchase
3.1
Shah Mihir

Chief Financial Officer

Officer
99,435 +43.6%
1.27
US$126,282 		99,435 +43.6% 1.27 US$126,282
2023-11-21 2023-11-17 S Sale
3.1
Hively Brad
Non-Executive Director
25,000 -3.5%
2.24
US$56,000 		25,000 -3.5% 2.24 US$56,000
2023-11-17 2023-11-17 PrS Proposed sale
3.1
Hively Brad

Director

Non-Executive Director
25,000
2.24
US$56,000 		25,000 2.24 US$56,000
2023-11-15 2023-11-13 S Sale
3.1
Hively Brad
Non-Executive Director
47,000 -6.1%
2.52
US$118,581 		47,000 -6.1% 2.52 US$118,581
2023-11-13 2023-11-13 PrS Proposed sale
3.1
Hively Brad

Director

Non-Executive Director
47,000
2.52
US$118,589 		47,000 2.52 US$118,589
2023-03-21 2023-03-17 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
10,000 +4.0%
0.55
US$5,500 		10,000 +4.0% 0.55 US$5,500
2023-03-21 2023-03-17 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
10,000 +4.2%
0.55
US$5,500 		10,000 +4.2% 0.55 US$5,500
2023-03-21 2023-03-17 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
2,146 +0.9%
0.55
US$1,176 		2,146 +0.9% 0.55 US$1,176
2023-03-21 2023-03-17 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
7,654 +3.4%
0.55
US$4,210 		7,654 +3.4% 0.55 US$4,210
2023-03-21 2023-03-17 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
9,948 +4.6%
0.55
US$5,471 		9,948 +4.6% 0.55 US$5,471
2023-03-21 2023-03-17 B Purchase
3.0
BARASCH RICHARD A
Non-Executive Director
200 +0.1%
0.55
US$110 		200 +0.1% 0.55 US$110
Explore more

More insider trading research around Oncology Institute Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America